DHODH is an independent prognostic marker and potent therapeutic target in neuroblastomaThale Kristin Olsen(University of Oslo), Ninib Baryawno(Karolinska Institutet)bioRxiv (Cold Spring Harbor Laboratory)September 25, 202110.1101/2021.09.25.461496Cited by 3SaveCiteExport RISWatch citationsRelated PapersFusion genes with<i>ALK</i>as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?|Neuro-Oncology|2015|51The Nordic ChiCaP Network: An interdisciplinary approach to childhood cancer predisposition|Rare|2025|0